Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription

Journal of Molecular Medicine

Volumn 84, Issue 11, 2006, Pages 919-931

  Bebermeier, Jan Hendrik ^a,e   Brooks, James D ^b   DePrimo, Samuel E ^b,f   Werner, Ralf ^a   Deppe, Uta ^a   Demeter, Janos ^b   Hiort, Olaf ^a   Holterhus, Paul Martin ^c,d  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e Eppendorf Vertrieb Deutschland GmbH   (Germany)

^f PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Androgen receptor; Coactivator; Coregulator; Corepressor; Microarray

Indexed keywords

ANDROGEN RECEPTOR; CAVEOLIN 1; PROSTATE SPECIFIC ANTIGEN; TUMOR PROTEIN;

ARTICLE; CELL LINE; CELL STRAIN LNCAP; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GENITAL SYSTEM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; UPREGULATION; WESTERN BLOTTING;

ANDROGENS; BLOTTING, WESTERN; CELL LINE, TUMOR; CLUSTER ANALYSIS; DATABASES, GENETIC; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 33750457376     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-006-0081-1     Document Type: Article

References (53)

1. Hiort O, Holterhus PM (2000) The molecular basis of male sexual differentiation. Eur J Endocrinol 142:101-1101
2. Vanderschueren D, Vandenput L, Boonen S, Lindberg MK, Bouillon R, Ohlsson C (2004) Androgens and bone. Endocr Rev 25:389-425
3. Claustres M, Sultan C (1988) Androgen and erythropoiesis: evidence for an androgen receptor in erythroblasts from human bone marrow cultures. Horm Res 29:17-22
4. Cohen C, Lawson D, DeRose PB (1998) Sex and androgenic steroid receptor expression in hepatic adenomas. Hum Pathol 29:1428-1432
5. Dorner G, Gotz F, Rohde W, Plagemann A, Lindner R, Peters H Ghanaati Z (2001) Genetic and epigenetic effects on sexual brain organization mediated by sex hormones. Neuro Endocrinol Lett 22:403-409
6. Meyer-Bahlburg HF, Dolezal C, Baker SW, Carlson AD, Obeid JS, New MI (2004) Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year-old girls with congenital adrenal hyperplasia. Arch Sex Behav 33:97-104
7. Andriole G, Bruchovsky N, Chung LW, Matsumoto AM, Rittmaster R, Roehrborn C, Russell D, Tindall D (2004) Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 172:1399-1403
8. Culig Z, Klocker H, Bartsch G, Steiner H, Hobisch A (2003) Androgen receptors in prostate cancer. J Urol 170:1363-1369
9. Fuller PJ (1991) The steroid receptor superfamily: mechanisms of diversity. FASEB J 5:3092-3099
10. Jenster G, van der Korput HA, van Vroonhoven C, van der Kwast TH, Trapman J, Brinkmann AO (1991) Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol 5:1396-1404
11. Laudet V, Gronemeyer H (2002) The Nuclear Receptor Facts-Book. First edition. Academic, London, UK
12. Shaffer PL, Jivan A, Dollins DE, Claessens F, Gewirth DT (2004) Structural basis of androgen receptor binding to selective androgen response elements. Proc Natl Acad Sci USA 101:4758-4763
13. Heinlein CA, Chang C (2002) Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
14. Hong H, Kohli K, Garabedian MJ, Stallcup MR (1997) GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol 17:2735-2744
15. Linja MJ, Porkka KP, Kang Z, Savinainen KJ, Janne OA, Tammela TL, Vessella RL, Palvimo JJ, Visakorpi T (2004) Expression of androgen receptor coregulators in prostate cancer. Clin Cancer Res 10:1032-1040
16. Truss M, Beato M (1993) Steroid hormone receptors: interaction with deoxyri-bonucleic acid and transcription factors. Endocr Rev 14:459-479
17. McEwan IJ (2004) Essays in biochemistry, the nuclear receptor family. In: Kumar R, Johnson BH, Thompson EB (eds) Overview of the structural basis for transcription regulation by nuclear hormone receptors, 1st edn. Portland Press, London, UK, pp. 27-39
18. Holterhus PM, Hiort O, Demeter J, Brown PO, Brooks JD (2003) Differential gene-expression patterns in genital fibroblasts of normal males and 46,XY females with androgen insensitivity syndrome: evidence for early programming involving the androgen receptor. Genome Biol 4:R37
19. Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, Bottero D, Vitale F, Migliaccio A, Auricchio F (2003) Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161:547-556
20. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD (2002) Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:R32
21. McPhaul MJ, Deslypere JP, Allman DR, Gerard RD (1993) The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o). J Biol Chem 268:26063-26066
22. McPhaul MJ, Schweikert HU, Allman DR, McPhaul MJ, Schweikert HU, Allman DR (1997) Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene. J Clin Endocrinol Metab 82:1944-1948
23. Holterhus PM, Salzburg J, Werner R, Hiort O (2005) Transactivation properties of wild-type and mutant androgen receptors in transiently transfected primary human fibroblasts. Horm Res 63:152-158
24. Gottlieb B, Beitel LK, Wu JH, Trifiro M (2004) The androgen receptor gene mutations database (ARDB): 2004 update. Hum Mutat 23:527-533
25. Shyamsundar R, Kim YH, Higgins JP, Montgomery K, Jorden M, Sethuraman A, van de Rijn M, Botstein D, Brown PO, Pollack JR (2005) A DNA microarray survey of gene expression in normal human tissues. Genome Biol 6:R22
26. Diehn M, Sherlock G, Binkley G, Jin H, Matese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA (2003) SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 31:219-223
27. Gollub J, Ball CA, Binkley G, Demeter J, Finkelstein DB, Hebert JM, Hernandez-Boussard T, Jin H, Kaloper M, Matese JC, Schroeder M, Brown PO, Botstein D, Sherlock G (2003) The Stanford Microarray Database: data access and quality assessment tools. Nucleic Acids Res 31:94-96
28. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868
29. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98:5116-5121
30. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408
31. Cleutjens CB, Steketee K, van Eekelen CC, van der Korput JA, Brinkmann AO, Trapman J (1997) Both androgen receptor and glucocorticoid receptor are able to induce prostate-specific antigen expression, but differ in their growth-stimulating properties of LNCaP cells. Endocrinology 138:5293-5300
32. Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM (2004) Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Cancer Res 64:3814-3822
33. Segawa T, Nau ME, Xu LL, Chilukuri RN, Makarem M, Zhang W, Petrovics G, Sesterhenn IA, McLeod DG, Moul JW, Vahey M, Srivastava S (2002) Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21:8749-8758
34. Dhanasekaran SM, Dash A, Yu J, Maine IP, Laxman B, Tomlins SA, Creighton CJ, Menon A, Rubin MA, Chinnaiyan AM (2005) Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. FASEB J 19:243-245
35. Qi H, Labrie Y, Grenier J, Fournier A, Fillion C, Labrie C (2001) Androgens induce expression of SPAK, a STE20/SPS1-related kinase, in LNCaP human prostate cancer cells. Mol Cell Endocrinol 182:181-192
36. Xu LL, Shanmugam N, Segawa T, Sesterhenn IA, McLeod DG, Moul JW, Srivastava S (2000) A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate. Genomics 66:257-263
37. Nasu Y, Timme TL, Yang G, Bangma CH, Li L, Ren C, Park SH, DeLeon M, Wang J, Thompson TC (1998) Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cells. Nat Med 4:1062-1064
38. Lin HK, Yeh S, Kang HY, Chang C (2001) Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Natl Acad Sci USA 98:7200-7205
39. Hayes SA, Zarnegar M, Sharma M, Yang F, Peehl DM, ten Dijke P, Sun Z (2001) SMAD3 represses androgen receptor-mediated transcription. Cancer Res 61:2112-2118
40. Schneikert J, Peterziel H, Defossez PA, Klocker H, Launoit Y, Cato AC (1996) Androgen receptor-Ets protein interaction is a novel mechanism for steroid hormone-mediated down-modulation of matrix metalloproteinase expression. J Biol Chem 271:23907-23913
41. Petre CE, Wetherill YB, Danielsen M, Knudsen KE (2002) Cyclin D1: mechanism and consequence of androgen receptor corepressor activity. J Biol Chem 277:2207-2215
42. Chen S, Wang J, Yu G, Liu W, Pearce D (1997) Androgen and glucocorticoid receptor heterodimer formation. A possible mechanism for mutual inhibition of transcriptional activity. J Biol Chem 272:14087-14092
43. Panet-Raymond V, Gottlieb B, Beitel LK, Pinsky L, Trifiro MA (2000) Interactions between androgen and estrogen receptors and the effects on their transactivational properties. Mol Cell Endocrinol 167:139-150
44. Wang M, Wang J, Zhang Z, Zhao Z, Zhang R, Hu X, Tan T, Luo S, Luo Z (2005) Dissecting phenotypic variation among AIS patients. Biochem Biophys Res Commun 335:335-342
45. Alen P, Claessens F, Verhoeven G, Rombauts W, Peeters B (1999) The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription. Mol Cell Biol 19:6085-6097
46. Pratt WB (1992) Control of steroid receptor function and cytoplasmic-nuclear transport by heat shock proteins. Bioessays 14:841-848
47. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (2001) Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276:13442-13451
48. Cho KA, Ryu SJ, Park JS, Jang IS, Ahn JS, Kim KT, Park SC (2003) Senescent phenotype can be reversed by reduction of caveolin status. J Biol Chem 278:27789-27795
49. Izbicka E, MacDonald JR, Davidson K, Lawrence RA, Gomez L, Von Hoff DD (1999) 5,6 Dihydro-5′-azacytidine (DHAC) restores androgen responsiveness in androgen-insensitive prostate cancer cells. Anticancer Res 19:1285-1291
50. Metzger E, Wissmann M, Yin N, Müller JM, Schneider R, Peters AHFM, Günther T, Buettmer R, Schüle R (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437:436-439
51. O'Malley B (2005) The biological and medical implications of steroid receptor coactivators. Presidential Plenary Session. Annual Meeting of the Endocrine Society, San Diego, CA, USA
52. Adachi M, Takayanagi R, Tomura A, Imasaki K, Kato S, Goto K, Yanase T, Ikuyama S, Nawata H (2000) Androgen-insensitivity syndrome as a possible coactivator disease. N Engl J Med 343:856-862
53. Deeb A, Mason C, Lee YS, Hughes IA (2005) Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome. Clin Endocrinol 63:56-62